By: Emily Miller, Kirk Willmarth, Dan Topler-Garcia
GLP-1 drugs result in notable drops in food spending. By 2030, as many as one in four Americans may have tried them.
Emily Miller is the Managing Editor at Drugwatch. With 13 years of professional journalism and editing experience, she combines her extensive knowledge of U.S. prescription drug prices with her personal journey as a patient living with Crohn’s disease, advocating for patient awareness and safety regarding medical products. Emily's work has been featured in various media outlets, including EastIdahoNews.com, Daily Mail, and Yahoo News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)


Not enough data
Emily's coverage is predominantly focused on local crime and breaking news, with a significant emphasis on reporting evolving stories. She also covers entertainment news to a notable extent. Given this focus, she may be interested in receiving pitches related to local crime incidents, ongoing legal cases or investigations in the Buffalo area, as well as developments in the entertainment industry.
For instance, if you have insights into local crime trends or specific cases within New York or more specifically Buffalo that align with her coverage areas and geographic focus, these could make for compelling pitch angles.
When reaching out to Emily Miller, highlighting data-driven insights and potential human-interest angles related to evolving local stories might increase the appeal of your pitch.
This information evolves through artificial intelligence and human feedback. Improve this profile .